Tirzepatide 40mg Vial
High-purity Tirzepatide 40mg research peptide from GenetiQ. Laboratory-tested and supplied as a lyophilized compound for controlled in vitro research applications.
Tirzepatide Vial 40mg
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its effects on metabolic function, insulin sensitivity, and body composition. It shares the same mechanism as the pharmaceutical compound Mounjaro and has been the subject of extensive published clinical research. The vial format is supplied for laboratory and research applications only.
Each vial contains 40mg lyophilised powder at ≥99% purity, third-party verified. Supplied with bacteriostatic water for reconstitution.
Research Areas
- Dual GIP/GLP-1 receptor agonism
- Metabolic function
- Insulin sensitivity
- Body composition research
Specifications
- 40mg lyophilised powder
- ≥99% purity, third-party verified
- Includes bacteriostatic water
- Store refrigerated, away from light
For laboratory and research purposes only. Not intended for human consumption or medical use.